Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Link opens in a new tab
Search content at Bar-Ilan University
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
The effect of the novel tellurium compound AS101 on autoimmune diseases
Gilad Halpert
, Benjamin Sredni
Department of Social & Health Sciences
Bar-Ilan University
Research output
:
Contribution to journal
›
Review article
›
peer-review
66
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The effect of the novel tellurium compound AS101 on autoimmune diseases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Autoimmune Disease
100%
AS101
100%
Tellurium Compounds
100%
Tellurium
33%
Plethora
16%
Clinical Efficacy
16%
Rare Elements
16%
Immune System
16%
Potential Therapeutics
16%
Redox
16%
Interleukin-17 (IL-17)
16%
Safety Profile
16%
Macrophages
16%
Human Body
16%
Autoimmune
16%
CD4+ T
16%
Relative Abundance
16%
Ammonium
16%
Immunomodulator
16%
Tellurate
16%
Autoreactive Cells
16%
Immunomodulatory Properties
16%
Psoriasis Disease
16%
Leukocyte Integrins
16%
Modulating Activity
16%
Diapedesis
16%
Incompatible Trace Elements
16%
Phase I Trial
16%
Regulatory T Cell(Treg)
16%
T Helper 17 Cells (Th17)
16%
Therapeutic Applications
16%
Immunology and Microbiology
Autoimmune Disease
100%
Regulatory T Cell
66%
Autoimmunity
33%
Immunomodulating Drugs
33%
Macrophage
33%
CD4
33%
Leukocyte
33%
Th17 Cell
33%
Diapedesis
33%
Interleukin 17
33%
Immune System
33%
Integrin
33%
In Vitro
33%